Home > Nexus Life Science Partners acquires Rigel Pharmaceuticals, Inc.
Transaction · Life Science

Nexus Life Science Partners acquires Rigel Pharmaceuticals, Inc.

Nexus Life Science Partners acquired Rigel Pharmaceuticals, Inc., a life science company in California, United States.

Deal at a glance

TargetRigel Pharmaceuticals, Inc. Buyer Nexus Life Science Partners SectorLife Science LocationCalifornia, United States ValueNot disclosed

Target company

Rigel Pharmaceuticals, Inc.
California, United States
Life Sciencesector
2016founded
Activestatus
View the company profile →

Buyer

Company · 8 deals on record
8deals, all time
4in this sector
2001latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Ollin Biosciences, Inc.Same sector and country · Nov 2026
OmnioseSame sector and country · Nov 2026
Orbus Therapeutics, Inc.Same sector and country · Oct 2026

Questions about this deal

Who acquired Rigel Pharmaceuticals, Inc.?Nexus Life Science Partners acquired Rigel Pharmaceuticals, Inc..

What type of deal was it?It was a transaction in the life science sector.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).